|
|
News Breaks | | | | September 26, 2012 | | 11:29 EDT |  | ABT | Abbott treatment for glioma granted orphan designation by EC
The grant, awarded August 9, was posted today to the European Commission website. Orphan designation was granted to Abbott Laboratories for humanised monoclonal antibody against epidermal growth factor receptor for the treatment of glioma. At the time of designation, glioma affected approximately 1 in 10,000 people in the European Union, or the equivalent of a total of around 51,000 people, according to the EC site. | |
|
News For ABT From The Last 14 Days Check below for free stories on ABT the last two weeks. |
|
|
| June 19, 2013 | | 08:45 EDT |  | ABT | Leerink's biotech analyst holds analyst/industry conference call on ADA
Analyst Antlaffy, along with Dr. George Grunberger, founder & Chairman of the Grunberger Diabetes Institute, preview the upcoming American Diabetes Association's conference, including perspectives on new devices in diabetes, potential disruptive technologies at ADA and progress towards the artificial pancreas on an Analyst/Industry conference call to be held on June 20 at 2 pm. | | | June 18, 2013 | | 07:28 EDT | | ABT | Wells Faro to host a conference
 Subscribe for More Information | | | June 14, 2013 | | 12:23 EDT | | ABT | Abbott announces new $3B share repurchase plan
Subscribe for More Information | | | 12:23 EDT | | ABT | Abbott announces new $3B share repurchase plan
| | | June 13, 2013 | | 11:02 EDT | | ABT | Leerink's major pharma analyst holds an analyst/Industry conference call
Subscribe for More Information | | | June 11, 2013 | | 09:33 EDT | | ABT | Abbott begins Absorb BVS clinical trial in Japan
Subscribe for More Information | | | June 6, 2013 | | 08:03 EDT |  | ABT | Abbott shares compelling, says Wells Fargo
Subscribe for More Information | |
|
|
|
|
|
|
